Attenuation of δ opioid receptor-mediated signaling by kainic acid in neural cells: Involvement of protein kinase C and intracellular Ca2+

Neuropharmacology

Volumn 38, Issue 7, 1999, Pages 991-998

  Ben, Li Hong ^a,b   Zhao, Jian ^a   Xin, Shun Mei ^a   Luo, Shen Qiu ^b   Pei, Gang ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Opioid receptor; cAMP accumulation; G protein activation; Kainate AMPA receptors; Kainic acid; Neural cells; Signal transduction

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ADENYLATE CYCLASE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; CYCLIC AMP; CYCLIC GMP; DELTA OPIATE RECEPTOR; DIZOCILPINE; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; FORSKOLIN; GLUTAMATE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; KAINIC ACID; KAINIC ACID RECEPTOR; METABOTROPIC RECEPTOR; MORPHINE; N METHYL DEXTRO ASPARTIC ACID; PROTEIN KINASE C;

ARTICLE; ATTENUATION; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; EXCITATORY AMINO ACID AGONISTS; GTP-BINDING PROTEINS; KAINIC ACID; MICE; NEURONS; PROTEIN KINASE C; RECEPTORS, AMPA; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0032969491     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00036-2     Document Type: Article

References (42)

1. Better B., Mulle C. Review: Neurotransmitter receptor II. AMPA and kainate receptors. Nature (Lond). 319:1995;329-331.
2. Bing G., Wilson B., Hudson P., Jin L., Feng Z., Zhang W., Bing R., Hong J.S. A single dose of kainic acid elevates the levels of enkephalins and activator protein-1 transcription factors in the hippocampus for up to 1 year. PNAS. 94(17):1997;9422-9427.
3. Cai Y.C., Zhang Y., Wu Y.L., Pei G. δ opioid receptor in neuronal cells undergoes acute and homologous desensitization. Biochem. Biophys. Res. Commun. 219:1996;342-347.
4. Cai Y.C., Ma L., Fan G.H., Zhao J., Jiang L.Z., Pei G. Activation of N-methyl-D-aspartate receptor attenuates acute responsiveness of δ-opioid receptors. Mol. Pharmacol. 51:1997;583-587.
5. Cheng Z.J., Fan G.H., Zhao J., Zhang Z., Jiang L.Z., Yang R., Pei G., Ma L. Endogenous opioid receptor-like receptor in human neuroblastoma SK-N-SH cells: activation of inhibitory G protein and homologous desensitization. Neuroreport. 8:1997;1913-1918.
6. 2+ in cultured frog rectal cells mediated by direct activation of NMDA receptor channels. Nature (Lond). 6:1991;259-267.
7. Fan G.H., Zhao J., Ma L., Wu Y.L., Lou L.G., Zhang Z., Jing Q., Pei G. N-methyl-D-aspartate attenuates opioid receptor-mediated G protein activation and it involves protein kinase C. Mol. Pharmacol. 53:1998;684-690.
8. 2+ release or protein kinase C activation significantly reduces the development of morphine dependence. Eur. J. Pharmacol. 300:1996;173-181.
9. Hescheler J., Rosenthal W., Trautwein W., Schultz G. The GTP-binding protein, Go, regulates neuronal calcium channels. Nature (Lond). 325:1987;445-447.
10. Hilf G., Gierschik P., Jakobs K.H. Muscarinic acetylcholine receptor-stimulated binding of 5′-O-(3-thiotriphosphate) to guanine nucleotide binding proteins in cardiac membranes. Eur. J. Biochem. 186:1989;725-731.
11. Iqbal Z. Excitatory amino acid receptor-mediated neuronal signal transduction: modulation by polyamines and calcium. Mol.-Cell-Biochem. 149-150:1995;233-240.
12. Jones K.A., Wilding T.J., Juettner J.E., Costa A.M. Desensitization of kainate receptors by kainate, glutamate and diastereomers of 4-methylglutamate. Neuropharmacology. 36(6):1997;853-863.
13. Kolaj M., Cerne R., Randic M. The opioid peptide dynorphin modulates AMPA and kainate responses in acutely isolated neurons from the dorsal horn. Brain-Res. 671(2):1995;227-244.
14. Law P.Y., Hom D.S., Loh H.H. Opiate receptor down-regulation and desensitization in neuroblastoma×glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Mol.-Pharmacol. 24(3):1983;413-424.
15. Lazareno S., Farries T., Birdsall N.J.M. Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected human muscarinic receptors m1-m4. Life Sci. 52:1993;449-456.
16. Louie A.E., Bass E.S., Zhan J., Law P.Y., Loh H.H. Attenuation of opioid receptor activity by phorbol ester in neuroblastoma×glioma NG 108-15 hybrid cells. J. Pharmacol. Exp. Ther. 253:1990;401-407.
17. 1 in neuroblastoma×glioma NG108-15 hybrid cells. FEBS letters. 403:1997;91-94.
18. MacDermott A.B., Mayer M.L., Westbrook G.L., Smith S.J., Baker J.L. NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature (Lond). 321:1986;519-522.
19. Mao J., Price D.D., Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci. 14(4):1994;2301-2312.
20. Mathew V.J., Westbrook G.L. The impact of receptor desensitization on fast synaptic transmission. TINS. 19(3):1996;96-101.
21. 2. Biochem. J. 267:1990;391-398.
22. Mercadante S., Lodi F., Sapio M., Calligara M., Serretta R. Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain. J. Pain. Sympt. Mgmt. 10:1995;564-568.
23. 1 receptor [see comments]. Nature. 377:1995;532-535.
24. 1 receptor. Eur.-J.-Pharmacol. 340(1):1997;1-15.
25. Murkin J.M. Central analgesic mechanisms: a review of opioid receptor physiopharmacology and related antinociceptive systems. J. Cardiothorac.-Vasc.-Anesth. 5(3):1991;268-277.
26. Nestler E.J. Under siege: the brain on opiates. Neuron. 16:1996;897-900.
27. Nestler E.J., Aghajanian G.K. Molecular and cellular basis of addiction. Science. 278:1997;58-63.
28. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science (Washington D.C.). 258:1992;607-614.
29. Reinscheid R., Nothacker H.P., Bourson A. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794.
30. Roerig S.C., Loh H.H., Law Y.Y. Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG 108-15 neuroblastoma×glioma hybrid cells. Mol. Pharmacol. 41:1992;822-831.
31. Satoh M., Minami M. Molecular pharmacology of the opioid receptors. Pharmacol.-Ther. 68(3):1995;343-364.
32. Self D.W., Nestler E.J. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18:1995;463-495.
33. Spinella M., Cooper M.L., Bodnar R.L. Excitatory amino acid antagonists in the rostral ventromedial medulla inhibit mesencephalic morphine analgesia in rats. Pain. 64(3):1996;545-552.
34. Tian W.N., Duzic E., Lanier S.M., Deth R.C. Determinants of α2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state. Mol. Pharmacol. 45:1994;524-531.
35. Tiseo P.J., Cheng J., Pasternak G.W., Inturrisi C.E. Modulation of morphine tolerance by the competitive N-metyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes. J. Pharmacol. Exp. Ther. 268:1994;195-201.
36. Traynor J.R., Nahouaki S.R. Modulation by δ-opioid agonists of guanosine-5′-O-3 (3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol. 47:1995;848-854.
37. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science (Washington D.C.). 251:1991;85-87.
38. Trujillo K.A., Akil H. Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists. Brain Res. 633:1994;178-188.
39. Wu Y.L., Pei G., Fan G.H. Inhibition of phospholipase C blocks opioid receptor-mediated activation of Gi proteins. Neuroreport. 9:1998;99-103.
40. Wang Y.Z., Small D.L., Stanimirovic D.B., Morley P., Durkin J.P. AMPA receptor-mediated regulation of a Gi-protein in cortical neurons. Nature. 389:1997;502-504.
41. Wickelgren I. Teaching the brain to take drugs. Science. 280:1998;2045-2047.
42. Zhao J., Zhang Y., Xin S.M., Ma L., Pei G. Attenuation of nociceptin/orphanin FQ-induced signaling by N-methyl-D-aspartate in neuronal cells. Neuroreport. 9:1998;631-636.